You are here

Prices & Quotes - UK Markets - Kromek Group (KMK)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
Up 16.13p
Change Today:
0.38p
Market Cap:
69.64m
Sector:
Medical Equipment and Services

Kromek reports solid momentum through second half

By Josh White

Date: Tuesday 11 May 2021

LONDON (ShareCast) - (Sharecast News) - Medical, security screening and nuclear detection technology company Kromek updated the market on its trading in the year just ended on Tuesday, confirming that after orders and shipments across its segments resumed in the final two months of the first half, it entered the second half with an "extensive" commercial pipeline and increased commercial activity.
The AIM-traded firm said that momentum continued through the rest of the year ended 30 April, as it delivered on previously-awarded contracts and won new orders.

As a result, it achieved "significant" sequential revenue growth in the second half over the first, and expected to report revenue and EBITDA for the year in line with market expectations.

The group said it was still maintaining tight cost control, improving collections and managing cash flow, resulting in its cash position at year-end being "slightly ahead" of market expectations.

"Specifically, in the second half of the year, progress was made in all of the group's business units," the board said in its statement.

"In the medical imaging segment, Kromek's customers increasingly rolled out their next-generation products, based on the group's technology, such as the group's original equipment manufacturer (OEM) customer that previously awarded a medical imaging contract expected to be worth up to $58.1m.

"The installation of the customer's medical imaging scanners, which is occurring in multiple countries, saw a ramp-up in the second half of the year as planned."

In the nuclear security segment, Kromek said it received new orders from government customers for D3S-related technologies.

That included a contract extension from its European government-related company customer, working with a European government to detect and protect against potential nuclear threats.

"The group added a new customer, a US government agency, for its D3S-ID product, received repeat orders from a US government customer for its CZT detectors for nuclear security applications, and received orders from the European Commission's Directorate-General for Migration and Home Affairs for the group's D3S Drone radiation detectors," the directors said.

"Kromek also received orders in the security screening segment, including for CZT modules to be designed into an advanced baggage screening system of a new US-based customer."

Kromek's board said it was "excited" about the potential for its new market segment of biological threat detection, reporting that during the second half, it began piloting its airborne Covid-19 detection solution at an airport and at another public place, which were progressing according to plan.

"Consequently, and combined with the successful fundraising completed in the second half of the 2021 financial year, the group is well-placed to capitalise on the opportunities across its business, and the board continues to look to the future with increased confidence.

"The group will provide further information at the time of its annual results announcement."

At 1442 BST, shares in Kromek Group were down 0.19% at 15.62p.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Kromek Group Market Data

Currency UK Pounds
Price 16.13p
Change Today 0.38p
52 Week High 21.48p
52 Week Low 12.70p
Volume 537,473
Shares Issued 431.85m
Market Cap 69.64m
Beta 0.06

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. empty sector
  5. empty sector
Price Trend
market
  1. half market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Income
Not Available
Growth
market
  1. full market star
  2. half market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
Price Chg 6m
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. half sector star
  4. empty sector
  5. empty sector
P/E
Not Available
PEG
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
Dividend Yield
Not Available
EPS Growth
Not Available
Operating Margin
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. empty sector
  4. empty sector
  5. empty sector

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Kromek Group Dividends

No dividends found

Trades for 26-Jan-2022

Time Volume / Share Price
13:47 2,999 @ 16.27p
13:20 24,490 @ 16.30p
13:03 12,254 @ 16.32p
13:00 2,553 @ 16.06p
12:44 50,000 @ 16.23p

Kromek Group Key Personnel

CEO Arnab Basu